$AB

AllianceBernstein Holding L.P. Stock 12‑Month Price Target Cut to $38.17, Implies 9% Upside

Analysts lowered AllianceBernstein Holding L.P.'s average price target from $39.5 to $38.17, with a range of $35 to $42. This implies a 9% upside from the Oct. 2 closing price. The consensus rating remains 'Hold' among 7 analysts.

Original reporting
Published Oct 5, 2026, 4:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 4:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AllianceBernstein Holding L.P. Stock 12‑Month Price Target Cut to $38.17, Implies 9% Upside — source image
Decision brief

The 30-second read

$ABBearishMed
01

Why it matters

Analyst target cuts often lead to short‑term price adjustments, especially when the consensus remains a hold.

02

Market read

Target reduction signals a modest downgrade, offering a potential short‑term trading edge.

03

What to watch

Potential upcoming earnings or fund flow changes could offset the target reduction.

Relevance 5/10Novelty 5/10Timing: post-market today

Background

The article reports a recent analyst consensus price‑target revision for AllianceBernstein.

Company-level read

Ticker impact

$ABBearishMedium confidence
Context

Analysts lowered the average price target for AllianceBernstein to $38.17, implying 9% upside.

Expected impact

likely downside as investors reassess valuation

Evidence & confidence

Analyst consensus downgrade signals weaker outlook, prompting sell pressure.

Market effects

May affect other asset‑management firms as analysts reassess sector valuations.

Limited to US equity markets.

Low

Counterpoint

Some investors may view the 9% implied upside as a buying opportunity despite the target cut.

Key entities

  • AllianceBernstein Holding L.P.

    US‑listed asset‑management firm (ticker AB).

Related articles

$ABLow

ALLIANCEBERNSTEIN HOLDING L.P. (AB): Ioanis Jorgali, Investors

ALLIANCEBERNSTEIN HOLDING L.P. (AB) filed an SEC Form 8-K — Regulation FD Disclosure. Ioanis Jorgali, Investors 629.213.6139 ioanis.jorgali@alliancebernstein.com Carly Symington, Media 629.213.5568 carly.symington@alliancebernstein.com AB Announces September 30, 2026 Assets Under Management Nashville, TN, October 12, 2026 - AllianceBernstein L.P. (“AB”) and Allian

$ABLow

AB Announces September 30, 2026 Assets Under Management

AllianceBernstein (NYSE: AB) reported a 2% decrease in assets under management to $900 billion in September 2026, driven by market depreciation and net outflows. Institutional channels saw inflows, offset by outflows in Retail and Private Wealth. Quarterly net inflows totaled $6.0 billion. The company issued forward-looking statements with typical cautionary language.

$ABMed

People moves: AllianceBernstein names Onur Erzan as next CEO

AllianceBernstein (AB) named Onur Erzan as its next CEO, effective April 1, 2027. Erzan, currently president, succeeds Seth Bernstein, who retires but remains on AB's board. AB's assets under management are $919 billion, with $169 billion in private wealth. Erzan joined AB in 2021 from McKinsey and has led key initiatives. AB is a subsidiary of Equitable Holdings.

$ABMedAI 8/10

AB Science raises EUR 14.2m to fund masitinib Phase III, AB8939

AB Science (Euronext Paris: AB) raised EUR 14.2m via a private placement to fund early steps of a strategic plan due in September. The issue created 23.28m new shares; an existing long-term investor provided EUR 12m. Proceeds target AB8939 in AML and masitinib Phase III in ALS. Cash is about EUR 23m, covering needs beyond 12 months.

$ABMed

AllianceBernstein Holding L.P. Q2 2026 Earnings Call Summary

Strategic Execution and Platform Scaling Achieved record AUM of $905 billion, driven by a return to positive organic growth and the strongest gross sales quarter in five years. Reached the $90 billion to $100 billion private markets AUM target more than a year ahead of schedule, validating a multi-year investment strategy in corporate lending and real estate debt.

$ABMed

AllianceBernstein Holding LP (AB) Q2 2026 Earnings Call Highlights: Record AUM

AllianceBernstein (AB) discussed Q2 2026 earnings call topics, including expectations for the Equitable Corebridge merger to add about $100B of AUM over a couple of years, with combined general account assets around $350B and separate around $200B. Management cited resilient private wealth adviser productivity, reduced expense guidance by $5-10M, and demand shifts in U.S. taxable fixed income.